Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-11-15-Speech-2-204"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20051115.25.2-204"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, in view of the European Parliament’s first reading of the draft regulation concerning the registration, evaluation, authorisation and restriction of chemicals, and whilst we approve of the role to be played by the European Agency, we must take a cautious position, because this text, even with all the amendments made to it, is full of holes and is far from being a success.
In addition, it does not seem to strike the desired balance between the three fundamental principles: protection of health and the environment, the competitiveness of business, innovation and substitution. This lack of precision results from the cost distortions that such a regulation would cause, which apparently range from EUR 3 to 180 billion, and from the benefits, which are estimated to amount to between EUR 5 and 230 billion. This disparity in the costs announced by the Commission, just like the costs put forward by the industry, is enormous. However, we must not forget that these costs will be borne solely by the industry, that this directive affects 5 million jobs and that it will have serious consequences. That is why we will not allow ourselves to be influenced by purely political statements and why we will assess the various amendments put forward on a case-by-case basis."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples